Sotalol-induced torsade de pointes: management with magnesium infusion.-Reference-Cited by-同舟云学术

Sotalol-induced torsade de pointes: management with magnesium infusion.

Published:1992-04-01 Issue:798 Volume:68 Page:289-290
ISSN:0032-5473
Container-title:Postgraduate Medical Journal
language:en
Short-container-title:Postgraduate Medical Journal

Author:

Arstall M. A.,Hii J. T.,Lehman R. G.,Horowitz J. D.

Publisher

BMJ

Subject

General Medicine

Reference12 articles.

1. syncope and torsade de pointes;McKibbin, J.K.; Pocock, W.A.; Barlow, J.B.; Millar, R.N.S.; Obel, I.W.P.Sotalol; hypokalaemia;Br Heart J

2. Torsade de pointes induced by sotalol despite therapeutic plasma sotalol concentrations;Krapf, R.; Gertsch, M.;Br Med J

3. Sotalol-induced torsade de pointes;Kuck, K.H.; Kunze, K.P.; Roewer, N.; Bleifeld, W.;Am Heart J

4. Hemiparesis in torsade de pointes under low dose sotalol therapy;Sieber, C.; Weiss, P.; Follath, F.;Schwteiz Med Worchenschr,1990

5. Torsade de pointes due to quinidine: observations in 31 patients;Bauman, J.L.; Bauernfeind, R.A.; Hoff, J.V.; Strasberg, B.; Swiryn, S.; Rosen, K.M.;Am Heart J

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beta-blocker and calcium-channel blocker toxicity: current evidence on evaluation and management;European Heart Journal: Acute Cardiovascular Care;2023-11-17

2. Toxicant-Induced Torsade de Pointes;Critical Care Toxicology;2017

3. Reduction over time of QTc prolongation in patients with sotalol after cardioversion of atrial fibrillation;Heart Rhythm;2016-03

4. Toxicant-Induced Torsade de Pointes;Critical Care Toxicology;2016

5. Cardiovascular Toxicity of Cardiovascular Drugs;Heart and Toxins;2015